FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1738689443> ?p ?o ?g. }

• W1738689443 endingPage "1009" @default.
• W1738689443 startingPage "999" @default.
• W1738689443 abstract "This study sought to demonstrate the 5-year clinical and functional multislice computed tomography angiographic results after implantation of the fully resorbable everolimus-eluting scaffold (Absorb BVS, Abbott Vascular, Santa Clara, California). Multimodality imaging of the first-in-humans trial using a ABSORB BVS scaffold demonstrated at 2 years the bioresorption of the device while preventing restenosis. However, the long-term safety and efficacy of this therapy remain to be documented. In the ABSORB cohort A trial (ABSORB Clinical Investigation, Cohort A [ABSORB A] Everolimus-Eluting Coronary Stent System Clinical Investigation), 30 patients with a single de novo coronary artery lesion were treated with the fully resorbable everolimus-eluting Absorb scaffold at 4 centers. As an optional investigation in 3 of the 4 centers, the patients underwent multislice computed tomography (MSCT) angiography at 18 months and 5 years. Acquired MSCT data were analyzed at an independent core laboratory (Cardialysis, Rotterdam, the Netherlands) for quantitative analysis of lumen dimensions and was further processed for calculation of fractional flow reserve (FFR) at another independent core laboratory (Heart Flow, Redwood City, California). Five-year clinical follow-up is available for 29 patients. One patient withdrew consent after 6 months, but the vital status of this patient remains available. At 46 days, 1 patient experienced a single episode of chest pain and underwent a target lesion revascularization with a slight troponin increase after the procedure. At 5 years, the ischemia-driven major adverse cardiac event rate of 3.4% remained unchanged. Clopidogrel was discontinued in all but 1 patient. Scaffold thrombosis was not observed in any patient. Two noncardiac deaths were reported, 1 caused by duodenal perforation and the other from Hodgkin’s disease. At 5 years, 18 patients underwent MSCT angiography. All scaffolds were patent, with a median minimal lumen area of 3.25 mm2 (interquartile range: 2.20 to 4.30). Noninvasive FFR analysis was feasible in 13 of 18 scans, which yielded a median distal FFR of 0.86 (interquartile range: 0.82 to 0.94). The low event rate at 5 years suggests sustained safety after the implantation of a fully bioresorbable Absorb everolimus-eluting scaffold. Noninvasive assessment of the coronary artery with an option of functional assessment could be an alternative to invasive imaging after treatment of coronary narrowing with such a polymeric bioresorbable scaffold. (ABSORB Clinical Investigation, Cohort A [ABSORB A] Everolimus-Eluting Coronary Stent System Clinical Investigation [ABSORB]; NCT00300131)" @default.
• W1738689443 created "2016-06-24" @default.
• W1738689443 creator A5026031312 @default.
• W1738689443 creator A5029693172 @default.
• W1738689443 creator A5036197968 @default.
• W1738689443 creator A5043375132 @default.
• W1738689443 creator A5049566889 @default.
• W1738689443 creator A5063792624 @default.
• W1738689443 creator A5080877318 @default.
• W1738689443 creator A5081547954 @default.
• W1738689443 date "2013-10-01" @default.
• W1738689443 modified "2023-09-28" @default.
• W1738689443 title "Five-Year Clinical and Functional Multislice Computed Tomography Angiographic Results After Coronary Implantation of the Fully Resorbable Polymeric Everolimus-Eluting Scaffold in Patients With De Novo Coronary Artery Disease" @default.
• W1738689443 cites W113768872 @default.
• W1738689443 cites W1966694114 @default.
• W1738689443 cites W1979539252 @default.
• W1738689443 cites W1990269665 @default.
• W1738689443 cites W1991519266 @default.
• W1738689443 cites W1998542677 @default.
• W1738689443 cites W2008197358 @default.
• W1738689443 cites W2036832512 @default.
• W1738689443 cites W2040113746 @default.
• W1738689443 cites W2046322851 @default.
• W1738689443 cites W2054094388 @default.
• W1738689443 cites W2055215555 @default.
• W1738689443 cites W2067824277 @default.
• W1738689443 cites W2072576022 @default.
• W1738689443 cites W2075557288 @default.
• W1738689443 cites W2080843536 @default.
• W1738689443 cites W2085016789 @default.
• W1738689443 cites W2086456362 @default.
• W1738689443 cites W2087150869 @default.
• W1738689443 cites W2089238503 @default.
• W1738689443 cites W2092579369 @default.
• W1738689443 cites W2095680098 @default.
• W1738689443 cites W2105141094 @default.
• W1738689443 cites W2107661763 @default.
• W1738689443 cites W2115088212 @default.
• W1738689443 cites W2125407517 @default.
• W1738689443 cites W2127548336 @default.
• W1738689443 cites W2127649313 @default.
• W1738689443 cites W2128592290 @default.
• W1738689443 cites W2134514183 @default.
• W1738689443 cites W2153259204 @default.
• W1738689443 cites W2160631086 @default.
• W1738689443 cites W2188834495 @default.
• W1738689443 cites W2232858378 @default.
• W1738689443 cites W3198624699 @default.
• W1738689443 cites W66253097 @default.
• W1738689443 doi "https://doi.org/10.1016/j.jcin.2013.05.017" @default.
• W1738689443 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24156961" @default.
• W1738689443 hasPublicationYear "2013" @default.
• W1738689443 type Work @default.
• W1738689443 sameAs 1738689443 @default.
• W1738689443 citedByCount "185" @default.
• W1738689443 countsByYear W17386894432013 @default.
• W1738689443 countsByYear W17386894432014 @default.
• W1738689443 countsByYear W17386894432015 @default.
• W1738689443 countsByYear W17386894432016 @default.
• W1738689443 countsByYear W17386894432017 @default.
• W1738689443 countsByYear W17386894432018 @default.
• W1738689443 countsByYear W17386894432019 @default.
• W1738689443 countsByYear W17386894432020 @default.
• W1738689443 countsByYear W17386894432021 @default.
• W1738689443 countsByYear W17386894432022 @default.
• W1738689443 countsByYear W17386894432023 @default.
• W1738689443 crossrefType "journal-article" @default.
• W1738689443 hasAuthorship W1738689443A5026031312 @default.
• W1738689443 hasAuthorship W1738689443A5029693172 @default.
• W1738689443 hasAuthorship W1738689443A5036197968 @default.
• W1738689443 hasAuthorship W1738689443A5043375132 @default.
• W1738689443 hasAuthorship W1738689443A5049566889 @default.
• W1738689443 hasAuthorship W1738689443A5063792624 @default.
• W1738689443 hasAuthorship W1738689443A5080877318 @default.
• W1738689443 hasAuthorship W1738689443A5081547954 @default.
• W1738689443 hasBestOaLocation W17386894431 @default.
• W1738689443 hasConcept C126322002 @default.
• W1738689443 hasConcept C126838900 @default.
• W1738689443 hasConcept C164705383 @default.
• W1738689443 hasConcept C2777987666 @default.
• W1738689443 hasConcept C2778213512 @default.
• W1738689443 hasConcept C2778283817 @default.
• W1738689443 hasConcept C2778583881 @default.
• W1738689443 hasConcept C2779464278 @default.
• W1738689443 hasConcept C2779699572 @default.
• W1738689443 hasConcept C2780911114 @default.
• W1738689443 hasConcept C3019004856 @default.
• W1738689443 hasConcept C500558357 @default.
• W1738689443 hasConcept C71924100 @default.
• W1738689443 hasConceptScore W1738689443C126322002 @default.
• W1738689443 hasConceptScore W1738689443C126838900 @default.
• W1738689443 hasConceptScore W1738689443C164705383 @default.
• W1738689443 hasConceptScore W1738689443C2777987666 @default.
• W1738689443 hasConceptScore W1738689443C2778213512 @default.
• W1738689443 hasConceptScore W1738689443C2778283817 @default.
• W1738689443 hasConceptScore W1738689443C2778583881 @default.
• W1738689443 hasConceptScore W1738689443C2779464278 @default.
• W1738689443 hasConceptScore W1738689443C2779699572 @default.

• next